ORGO Q1 2019 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena

ORGOOrganogenesis Holdings Inc.

$338M

Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$57M

Gross Profit

$40M70.3% margin

Operating Income

-$12M-21.2% margin

Net Income

-$16M-27.4% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

-10.2%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$224,000

Balance Sheet

Total Assets

$176M

Total Liabilities

$144M

Stockholders' Equity

$33M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57M	$0	—
Gross Profit	$40M	-$1M	+3564.1%
Operating Income	-$12M	-$1M	-946.0%
Net Income	-$16M	-$135,653	-11448.6%

Revenue Segments

Advanced Wound care

$48M84%

Surgical and Sports Medicine

$9M16%